Headlands Technologies LLC Zai Lab LTD Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$13.72 - $21.55 $32,365 - $50,836	-2,359 Reduced 59.41%	1,612 $27,000
Q1 2024 May 07, 2024	BUY	$15.95 - $26.8 $63,337 - $106,422	3,971 New	3,971 $63,000
Q3 2023 Nov 09, 2023	SELL	$22.72 - $31.49 $78,906 - $109,364	-3,473 Reduced 99.06%	33 $0
Q2 2023 Aug 03, 2023	BUY	$25.3 - $39.67 $88,701 - $139,083	3,506 New	3,506 $97,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.